Holen Sie sich die Stockscreener-App
6.00
3.45%
0.20
Handel nachbörslich:
5.98
-0.02
-0.33%
Schlusskurs vom Vortag:
$5.80
Offen:
$5.73
24-Stunden-Volumen:
164.91K
Relative Volume:
1.85
Marktkapitalisierung:
$149.85M
Einnahmen:
$32.83M
Nettoeinkommen (Verlust:
$2.23M
KGV:
-25.00
EPS:
-0.24
Netto-Cashflow:
$9.27M
1W Leistung:
+2.92%
1M Leistung:
+30.43%
6M Leistung:
+60.00%
1J Leistung:
+43.88%
1-Tages-Spanne:
$5.72
$6.25
1-Wochen-Bereich:
$5.40
$6.25
52-Wochen-Spanne:
$3.03
$6.25
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Acadian Asset Management LLC Has $395,000 Stock Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Thompson Siegel & Walmsley LLC Takes $420,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat
Eton Pharmaceuticals stock hits 52-week high at $5.26 - Investing.com
Opaleye Management Inc. buys Eton Pharmaceuticals shares worth over $500k - Investing.com India
Opaleye Management Inc. buys Eton Pharmaceuticals shares worth over $500k - Investing.com
After Leaping 26% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar - Simply Wall St
Equities Analysts Offer Predictions for Eton Pharmaceuticals, Inc.’s Q3 2024 Earnings (NASDAQ:ETON) - Defense World
Equities Analysts Offer Predictions for Eton Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ETON) - MarketBeat
Analyzing Fulcrum Therapeutics (NASDAQ:FULC) and Eton Pharmaceuticals (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expected to Post FY2025 Earnings of $0.31 Per Share - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) to Post FY2025 Earnings of $0.31 Per Share, HC Wainwright Forecasts - MarketBeat
Eton Pharmaceuticals’ (ETON) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Earns Buy Rating from HC Wainwright - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 7.4% in August - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Update - MarketBeat
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Eton Pharmaceuticals (NASDAQ:ETON) Trading Up 2.7% - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Trading 2.7% Higher - Defense World
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Thinking about buying stock in Cellebrite DI, Milestone Pharmace - GuruFocus.com
When Will Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Breakeven? - Simply Wall St
Earnings call: Eaton Pharmaceuticals sees surge in product sales, eyes PKU market - Investing.com Australia
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2024 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript - Seeking Alpha
ETONEton Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - GlobeNewswire
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - StockTitan
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - Yahoo Finance
Eton Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Eton Pharmaceuticals And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Eton Pharmaceuticals And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Eton Pharmaceuticals (ETON) to Release Quarterly Earnings on Thursday - MarketBeat
Eton Pharmaceuticals (ETON) Scheduled to Post Earnings on Thursday - Defense World
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewswire
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - ForexTV.com
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - StockTitan
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Purchased by Acadian Asset Management LLC - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Trading 0.3% Higher - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Trading Up 0.3% - Defense World
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update - Victoria Advocate
Eton stock gains on regulatory update (NASDAQ:ETON) - Seeking Alpha
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral - EIN News
FDA sets review date for Eton's hydrocortisone solution - Investing.com
Stocks to Watch: Eton Pharmaceuticals, Match Group, Trump Media & Technology Group - MarketWatch
Upstart holdings CTO sells shares worth over $258k - Investing.com
Eton Pharma Shares Rise After FDA Accepts New Drug Application for ET-400 - MarketWatch
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - WICZ
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 ... - The Bakersfield Californian
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - GlobeNewswire
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.23%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):